Key facts
- Notable investors include Fil Rouge Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Moltech Innovations
- ·The full record, as it builds
Funding rounds
No funding rounds for Moltech Innovations are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Moltech Innovations
Operator of a biotechnology company intended to offer artificial intelligence-based discovery of compounds for the treatment of chronic diseases. The company's platform uses generative artificial intelligence to continually improve molecules, fine-tuning their properties to enhance drug effectiveness, minimize side effects, and improve overall safety profiles, enabling medical professionals to use new treatments for patients suffering from chronic ailments.
- Sector
- Healthcare
- HQ
- Zagreb, Croatia
- Founded
- 2025
- Employees
- 2
- Website
- moltech-innovations.com/
- Ownership
- Privately Held (backing)
Moltech Innovations doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Moltech Innovations shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Moltech Innovations in its N-PORT filings yet. We sweep new filings monthly.